Astrazeneca
-
Coronavirus: UK identifies 30 cases of blood clots in AstraZeneca vaccine recipients
Scroll Staff
-
Coronavirus: Bharat Biotech, AstraZeneca studying vaccine shots for children, says AIIMS chief
Scroll Staff
-
Covid-19: AstraZeneca revises vaccine efficacy to 76% after US body flagged outdated data in trials
Scroll Staff
-
India temporarily halts export of Covid vaccines to meet local demand as infections surge: Reports
Scroll Staff
-
Covid-19: AstraZeneca may have provided outdated data for vaccine trial, says US medical body
Scroll Staff
-
Increase gap between two doses of Covishield vaccine to 4-8 weeks, Centre tells states
Scroll Staff
-
Coronavirus: AstraZeneca vaccine shows 79% efficacy in US trial
Scroll Staff
-
Good news: EU nations have resumed Oxford vaccine. Bad news: They don’t have enough doses
Megan Clement, The Conversation
-
Covid-19: Countries to resume using AstraZeneca vaccine after European drug regulator finds it safe
Scroll Staff
-
Coronavirus: AstraZeneca vaccine is safe and effective, says Europe’s drug regulator
Scroll Staff
-
Coronavirus: No concern regarding use of AstraZeneca’s Covishield vaccine in India, says Centre
Scroll Staff
-
The big news: Amid protests, FM says not all banks will be privatised, and 9 other top stories
Scroll Staff
-
WHO defends AstraZeneca vaccine after France, Germany, Italy join countries suspending its use
Scroll Staff
-
Covid-19: AstraZeneca says no higher risk of blood clots as Netherlands, Ireland suspend its vaccine
Scroll Staff
-
Covid-19: India looking at all ‘serious’ side effects amid safety concerns about AstraZeneca vaccine
Scroll Staff
-
Coronavirus: No reason to stop using AstraZeneca vaccine, says WHO after countries suspend rollout
Scroll Staff
-
Covid: AstraZeneca-Oxford vaccine more effective with 3-month gap before second dose, shows study
Scroll Staff
-
Coronavirus: AstraZeneca vaccine effective against UK variant, says Oxford University
Scroll Staff
-
Coronavirus: Oxford vaccine gives good immune response in elderly, says trial chief amid controversy
Scroll Staff
-
Explainer: Why the EU has picked a fight with AstraZeneca over Covid-19 vaccines
Aditya Goenka, The Conversation